A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer

Eur J Cancer. 1995 Sep;31A(10):1721. doi: 10.1016/0959-8049(95)00310-f.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antidotes / administration & dosage*
  • Cisplatin / adverse effects*
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Glutathione / administration & dosage*
  • Hearing / drug effects
  • Humans
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antidotes
  • Glutathione
  • Cisplatin